Laboratory diagnosis of Clostridioides difficile infection: guidelines and status of practice in Korea
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Clostridioides difficile infection (CDI) is a common healthcare-associated infection that is expected to increase with the increases in the elderly population, immunocompromised patients treated with chemotherapy and immunosuppressive drugs, antimicrobial-resistant bacteria, and invasive medical technologies. Accurate diagnosis is critical for proper treatment and management of CDI. Clinical laboratories typically use four methods to diagnose CDI: C. difficile culture, toxin detection using immunoassays, detection of glutamate dehydrogenase using immunoassays, and detection of toxin A/B gene. Each CDI diagnostic test has strengths and limitations, and varies in performance. Guidelines for CDI diagnosis have been developed by organizations that include the European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America/Society for Healthcare Epidemiology of America, and American College of Gastroenterology. Certain other countries have guidelines. In Korea, surveys on CDI diagnosis performed in 2015 and 2018 revealed a shift in CDI testing in clinical laboratories in Korea. It is necessary to develop standardized diagnostic guidelines for CDI appropriate for the Korean context.
Abstract
Clostridioides difficile infection (CDI) is a common healthcare-associated infection that is expected to increase with the increases in the elderly population, immunocompromised patients treated with chemotherapy and immunosuppressive drugs, antimicrobial-resistant bacteria, and invasive medical technologies. Accurate diagnosis is critical for proper treatment and management of CDI. Clinical laboratories typically use four methods to diagnose CDI: C. difficile culture, toxin detection using immunoassays, detection of glutamate dehydrogenase using immunoassays, and detection of toxin A/B gene. Each CDI diagnostic test has strengths and limitations, and varies in performance. Guidelines for CDI diagnosis have been developed by organizations that include the European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America/Society for Healthcare Epidemiology of America, and American College of Gastroenterology. Certain other countries have guidelines. In Korea, surveys on CDI diagnosis performed in 2015 and 2018 revealed a shift in CDI testing in clinical laboratories in Korea. It is necessary to develop standardized diagnostic guidelines for CDI appropriate for the Korean context.
참고문헌 (16)
- Lessa FC, "Burden of Clostridium difficile infection in the United States", N Engl J Med, 372, pp.825~834 (2015)
- Bagdasarian N, "Diagnosis and treatment of Clostridium difficile in adults : a systematic review", JAMA, 313, pp.398~408 (2015)
- Czepiel J, "Clostridium difficile infection : review", Eur J Clin Microbiol Infect Dis, 38, pp.1211~1221 (2019)
- "Antibiotic resistance threats in the United States" (2019)[URL]
- Byun JH, "A nationwide study of molecular epidemiology and antimicrobial susceptibility of Clostridioides difficile in South Korea", Anaerobe, 60, pp.102106~ (2019)
- Kim J, "Active surveillance of Clostridioides difficile infections in 10 tertiary hospitals", Infect Chemother, 53(Suppl 2), pp.S264~ (2021)
- Son KJ, "The trend of Clostridioides difficile infection in Korean hospitals with the analysis of nationwide sample cohort", Ann Clin Microbiol, 23, pp.241~249 (2020)
- Martinez-Melendez A, "Current knowledge on the laboratory diagnosis of Clostridium difficile infection", World J Gastroenterol, 23, pp.1552~1567 (2017)
- Planche T, "Diagnostic pitfalls in Clostridium difficile infection", Infect Dis Clin North Am, 29, pp.63~82 (2015)
- Chung HS, "Nationwide survey for current status of laboratory diagnosis of Clostridioides difficile infection in Korea", J Korean Med Sci, 37, pp.e38~ (2022)
- Chung HS, "Laboratory diagnosis of Clostridium difficile infection in Korea : the first national survey", Ann Lab Med, 39, pp.317~321 (2019)
- Crobach MJ, "European Society of Clinical Microbiology and Infectious Diseases : update of the diagnostic guidance document for Clostridium difficile infection", Clin Microbiol Infect, 22(Suppl 4), pp.S63~81 (2016)
- Chung HS, "Laboratory diagnostic methods for Clostridioides difficile infection : the first systematic review and meta-analysis in Korea", Ann Lab Med, 41, pp.171~180 (2021)
- Kraft CS, "A laboratory medicine best practices systematic review and meta-analysis of nucleic acid amplification tests(NAATs)and algorithms including NAATs for the diagnosis of Clostridioides(Clostridium)difficile in adults", Clin Microbiol Rev, 32, pp.e00032~18 (2019)
- McDonald LC, "Clinical practice guidelines for Clostridium difficile infection in adults and children : 2017 update by the Infectious Diseases Society of America(IDSA)and Society for Healthcare Epidemiology of America(SHEA)", Clin Infect Dis, 66, pp.987~994 (2018)
- Kelly CR, "ACG clinical guidelines : prevention, diagnosis, and treatment of Clostridioides difficile infections", Am J Gastroenterol, 116, pp.1124~1147 (2021)